A detailed history of Wells Fargo & Company transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Wells Fargo & Company holds 52,167 shares of AMRN stock, worth $22,953. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,167
Previous 78,933 33.91%
Holding current value
$22,953
Previous $54,000 40.74%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.57 - $0.8 $15,256 - $21,412
-26,766 Reduced 33.91%
52,167 $32,000
Q2 2024

Aug 13, 2024

BUY
$0.63 - $1.07 $16,233 - $27,570
25,767 Added 48.47%
78,933 $54,000
Q1 2024

May 10, 2024

SELL
$0.82 - $1.35 $1,836 - $3,024
-2,240 Reduced 4.04%
53,166 $47,000
Q4 2023

Feb 09, 2024

SELL
$0.66 - $0.91 $15,345 - $21,157
-23,250 Reduced 29.56%
55,406 $48,000
Q3 2023

Nov 13, 2023

BUY
$0.85 - $1.43 $4,291 - $7,220
5,049 Added 6.86%
78,656 $72,000
Q2 2023

Aug 15, 2023

SELL
$1.12 - $1.49 $28,809 - $38,327
-25,723 Reduced 25.9%
73,607 $87,000
Q1 2023

May 12, 2023

SELL
$1.19 - $2.19 $5,071 - $9,333
-4,262 Reduced 4.11%
99,330 $148,000
Q4 2022

Feb 13, 2023

SELL
$1.07 - $1.34 $32,576 - $40,796
-30,445 Reduced 22.71%
103,592 $125,000
Q3 2022

Nov 14, 2022

SELL
$1.09 - $1.67 $15,129 - $23,179
-13,880 Reduced 9.38%
134,037 $146,000
Q2 2022

Aug 12, 2022

SELL
$1.13 - $3.69 $36,999 - $120,821
-32,743 Reduced 18.12%
147,917 $220,000
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $29,526 - $38,642
10,360 Added 6.08%
180,660 $595,000
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $79,311 - $126,801
-24,479 Reduced 12.57%
170,300 $574,000
Q3 2021

Nov 15, 2021

SELL
$3.94 - $5.84 $237,463 - $351,976
-60,270 Reduced 23.63%
194,779 $994,000
Q2 2021

Aug 16, 2021

SELL
$4.26 - $6.5 $16,498 - $25,174
-3,873 Reduced 1.5%
255,049 $1.12 Million
Q1 2021

May 13, 2021

SELL
$5.03 - $8.8 $171,452 - $299,956
-34,086 Reduced 11.63%
258,922 $1.61 Million
Q4 2020

Feb 09, 2021

BUY
$4.04 - $5.31 $277,527 - $364,770
68,695 Added 30.62%
293,008 $1.43 Million
Q3 2020

Nov 05, 2020

BUY
$3.64 - $7.76 $140,733 - $300,024
38,663 Added 20.83%
224,313 $945,000
Q2 2020

Aug 13, 2020

BUY
$4.78 - $8.26 $131,540 - $227,306
27,519 Added 17.4%
185,650 $1.29 Million
Q1 2020

May 14, 2020

BUY
$4.0 - $21.53 $632,524 - $3.4 Million
158,131 New
158,131 $632,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.